Jian Wu photo
Jian Wu
Lawyer
Shanghai
43rd Floor
HKRI Centre One, HKRI Taikoo Hui
288 Shimen Yi Road
Shanghai, 200041
People's Republic of China (PRC)
+86 130 6165 0071
jian.wu@kobrekim.com

Jian Wu represents clients in cross-border matters involving high-stakes commercial disputes and investigations across the Asia Pacific region. Mr. Wu has particular experience with multijurisdictional investigations and compliance reviews involving allegations of fraud, bribery, corruption and money laundering. He frequently advises state-owned enterprises, multinational corporations and financial institutions on global compliance matters in terms of anti-corruption, data privacy, export controls, as well as sanctions imposed by government authorities and multilateral development banks.

Mr. Wu also represents corporate clients in the resolution of complex cross-border disputes through arbitration and litigation. He helps clients tailor, design, develop and implement global strategies across multiple jurisdictions including Mainland China, Hong Kong, the United States, the United Kingdom and other offshore jurisdictions such as the British Virgin Islands and Cayman Islands.

Before joining Kobre & Kim, Mr. Wu practiced at Paul Hastings, focusing on internal investigations and compliance reviews. Prior to that, he practiced at Mayer Brown JSM in Beijing, China, and Hong Kong, where he advised Chinese enterprises preparing for U.S. court proceedings and non-Chinese enterprises in various disputes, bankruptcy matters and local investigations.

Admissions

  • New York

Education

  • New York University School of Law, LLM
  • China University of Hong Kong, LLM
  • China University of Political Science and Law, LLB

Languages

  • Mandarin

Accolades

  • The Legal 500 Asia-Pacific, Regulatory/Compliance - China
  • The Legal 500 Asia-Pacific, Dispute Resolution: Litigation - China

Select Engagements

  • Represented an Asia-based business executive and his affiliated entities in global legal matters arising out of allegations of fraud, bribery and money laundering, which involve criminal investigations and civil asset forfeiture proceedings brought by the U.S. Department of Justice, as well as additional legal actions from authorities located in Switzerland, Saudi Arabia, the United Arab Emirates, Singapore and various other countries and regions, involving several billions of USD in controversy.
  • Conducted internal investigations for the U.S. affiliates of a Chinese listed company into alleged fraud and misconduct by its senior officers.
  • Represented the U.S. subsidiaries of a Chinese company in criminal investigations brought by the U.S. Department of Justice into alleged bribery and corruption in relation to the company’s operations in Asia and Africa.
  • Represented an international petroleum and gas company in the Delaware civil proceedings against its competitors headquartered in Spain and Argentina.
  • Represented a multinational medical device corporation in internal investigations of its operations in China in connection with voluntary disclosure to the U.S. Department of Justice relating to potential FCPA violations.
  • Represented a European multinational business software corporation in internal investigations of its operations in Greater China in connection with whistleblower allegations, revenue recognition and suspected fraudulent practices.
  • Advised an Asia-based company on sanction for integrity violations imposed by Asian Development Bank.
  • Represented a Chinese internet software corporation in assessing compliance relating to U.S. economic sanctions, trade controls, data privacy, and cross-border regulatory issues leading to potential enforcement risks.
  • Advised a U.S. multinational technology corporation on sanction compliance issues in connection with companies on the Entity List imposed by U.S. Department of Commerce’s Bureau of Industry and Security.
  • Represented a Chinese integrated technology manufacturing corporation for compliance relating to U.S. economic sanctions and trade controls, and potential litigation arising out of technology transfer and related issues.
  • Represented a British multinational pharmaceutical company in internal compliance reviews of its operations in China in connection with its global acquisition with another leading pharmaceutical company.
  • Advised a Canadian telecommunication corporation on winding up of its businesses and operations in Asia Pacific Region.

Professional & Community Involvement

  • American Bar Association, China Committee, Steering Group Member
  • Asian American Bar Association of New York, Asia Practice Committee, Co-Chair
  • New York City Bar Association, Asian Affairs Committee, Co-Chair

Publications & Presentations

  • Co-author, "'Belt and Road Initiative' Chinese Companies Should Pay Attention to MDB Compliance (中国企业“一带一路”走出去需重视多边开发银行合规)" (Guancha News, August 2021)
  • Speaker, “Potential Impact of Recent Executive Orders on Chinese Investments and Business in the United States” (New York City Bar Association, Webinar, September 2020)
  • Co-author, “Why Anti-Bribery Enforcement Scrutiny in China is Here to Stay” (Global Investigations Review, May 2020)
  • Speaker, “Dealing with Chinese Parties: Litigation, White Collar Crimes, and Transactional Opportunities In The Era of the Trade War” (New York City Bar Association, New York, October 2019)
  • Speaker, “The Long Arm of the Law: What the Extra-Territorial Tools of the Department of Justice Mean for Asian Companies and Individuals” (New York City Bar Association, New York, September 2019)
  • Speaker, “China’s Belt and Road Initiative: How to Navigate New Business Opportunities” (New York City Bar Association, New York, June 2019)
  • Speaker, “Risks and Strategies for Foreign Companies Involved in U.S. Litigation” (Asian American Bar Association of New York, New York, March 2018)

Attorney Advertising. Prior results do not guarantee a similar outcome.